These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 20203626)
1. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers. Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626 [TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
3. Relationship between hyperuricemia and chronic kidney disease. Ohno I Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1039-44. PubMed ID: 22132954 [TBL] [Abstract][Full Text] [Related]
4. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
5. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Talaat KM; el-Sheikh AR Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758 [TBL] [Abstract][Full Text] [Related]
6. Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia. Cuspidi C; Valerio C; Sala C; Meani S; Esposito A; Zanchetti A; Mancia G Am J Hypertens; 2007 Jun; 20(6):678-85. PubMed ID: 17531928 [TBL] [Abstract][Full Text] [Related]
7. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia. Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830 [TBL] [Abstract][Full Text] [Related]
8. [The future of renin inhibition]. Uresin AY; Baran E Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475 [TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers? Ruilope LM Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118 [TBL] [Abstract][Full Text] [Related]
10. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia. Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712 [TBL] [Abstract][Full Text] [Related]
11. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms. Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
14. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial. McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765 [TBL] [Abstract][Full Text] [Related]
15. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients. Kostka-Jeziorny K; Uruski P; Tykarski A Blood Press; 2011 Apr; 20(2):104-10. PubMed ID: 21405957 [TBL] [Abstract][Full Text] [Related]
16. Establishing a new option for target-organ protection: rationale for ARB plus ACE inhibitor combination therapy. Cohn JN; Goldman JM Am J Hypertens; 2008 Mar; 21(3):248-56. PubMed ID: 18219303 [TBL] [Abstract][Full Text] [Related]
18. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660 [TBL] [Abstract][Full Text] [Related]
20. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Takemori K; Ishida H; Ito H Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]